Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fed Conditions
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 32
- Registration Number
- NCT00778739
- Locations
- 🇨🇦
Biovail Contract Research,, Toronto, Ontario, Canada
Bioequivalence Study of Cyclobenzaprine Hydrochloride 10 mg Tablets, USP Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 40
- Registration Number
- NCT00778037
- Locations
- 🇮🇳
Ranbaxy CPU, Gurgaon, Haryana, India
Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 42
- Registration Number
- NCT00778726
- Locations
- 🇺🇸
aaiPharma, Inc, Chapel Hill, North Carolina, United States
Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg-42.9 mg/ 5 mL Oral Suspension Under Fed Conditions
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- Drug: amoxicillin-clavulanic acid 600 mg- 42.9 mg/ 5 mL oral suspension
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 48
- Registration Number
- NCT00778544
- Locations
- 🇨🇦
Anapharm, Quebec, Canada
Bioequivalence Study of Fosinopril Sodium / Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fed Conditions
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 33
- Registration Number
- NCT00778713
- Locations
- 🇺🇸
Gateway Medical Research Inc, St. Charles, Missouri, United States
Bioequivalence Study of Gabapentin 400 mg Capsules Under Fasting Conditions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 26
- Registration Number
- NCT00778271
- Locations
- 🇨🇦
MDS Pharma Services, Saint-Laurent,, Quebec, Canada
Bioequivalence Study of Cefprozil Tablets, USP 500 mg Under Fasting Conditions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 27
- Registration Number
- NCT00778778
- Locations
- 🇨🇦
MDS Pharma Services, Saint-Laurent, Montreal, Quebec, Canada
Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 40
- Registration Number
- NCT00778661
- Locations
- 🇺🇸
MDS Pharma Services, Phoenix, Arizona, United States
A Comparitive Bioavailability Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fasting Conditions and After Low and High Fat Meal
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 34
- Registration Number
- NCT00778349
Bioequivalence Study of Nitrofurantoin 100 mg Capsules Under Fed Conditions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 40
- Registration Number
- NCT00778583
- Locations
- 🇮🇳
Ranbaxy Research Laboratories, Gurgaon, Haryana, India
© Copyright 2025. All Rights Reserved by MedPath